N-tert.-butyloxycarbonyl-L-serinal | 91103-36-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-tert.-butyloxycarbonyl-L-serinal
• 英文别名: N-Boc-L-serinal；tert-butyl [(2S)-1-hydroxy-3-oxopropan-2-yl]carbamate；N-boc-L-serine；tert-butyl N-[(2S)-1-hydroxy-3-oxopropan-2-yl]carbamate
• CAS: 91103-36-5
• 化学式: C₈H₁₅NO₄
• 分子量: 189.211
• InChiKey: IQUPBNVUTOSSFI-ZCFIWIBFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-tert.-butyloxycarbonyl-L-serinal 在 platinum(IV) oxide ruthenium(IV) oxide 、 sodium periodate 、 氢气 作用下， 以 乙腈 为溶剂， 生成 BOC-D-谷氨酸5-叔丁酯
  参考文献：
  名称：

  从D-氨基葡萄糖盐酸盐手性合成氨基酸，氨基醛和氨基醇。N-boc-L-serinal的多重图合成

  摘要：

  N-叔丁氧羰基-L-丝氨酸易于从D-氨基葡萄糖盐酸盐分三步制备。通用的合成中间体具有较长的化学和构型稳定性，可与各种稳定的磷酰化物反应，以高收率生产对映体纯的（ee <95％）烯丙基氨基醇。

  DOI：

  10.1016/s0040-4039(00)88778-x
• 作为产物：
  描述：

  Boc-L-丝氨酸甲酯 在 咪唑 、 二异丁基氢化铝 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 122.0h， 生成 N-tert.-butyloxycarbonyl-L-serinal
  参考文献：
  名称：

  Intramolecular Pictet-Spengler reaction of N-alkoxytryptamines. 3. Stereoselective synthesis of (-)-debromoeudistomin L and (-)-O-methyldebromoeudistomin E and their stereoisomers

  摘要：

  DOI：

  10.1021/jo00300a011

文献信息

• [EN] 1,2,4-TRIAZOLYLAMINOARYL (HETEROARYL) SULFONAMIDE DERIVATIVES<br/>[FR] DERIVES DE 1,2,4-TRIAZOLYLAMINOARYL(HETEROARYL)SULFONAMIDE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2006042215A1

  公开（公告）日：2006-04-20

  1,2,4 Triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I), pharmaceutically acceptable salts thereof, processes for the manufacture of 1,2,4 triazolylaminoaryl(heteroaryl) sulfonamide derivatives and pharmaceutical compositions containing 1,2,4 triazolylaminoaryl (heteroaryl)sulfonamide derivatives are disclosed: Formula (I) The 1,2,4 triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I) possess cell cycle inhibitory activity and are accordingly useful for their anti cell proliferation (such as anti cancer) activity.

  1,2,4-三唑基氨基芳基（杂芳基）磺酰胺衍生物的公式（I）、药用可接受的盐、1,2,4-三唑基氨基芳基（杂芳基）磺酰胺衍生物的制造工艺以及包含1,2,4-三唑基氨基芳基（杂芳基）磺酰胺衍生物的药物组合物被披露：公式（I）的1,2,4-三唑基氨基芳基（杂芳基）磺酰胺衍生物具有细胞周期抑制活性，因此可用于其抗细胞增殖（如抗癌）活性。
• AMIDE DERIVATIVES OF ANILINE-RELATED COMPOUNDS AND COMPOSITIONS THEREOF
  申请人：C&C BIOPHARMA, LLC

  公开号：US20150284360A1

  公开（公告）日：2015-10-08

  Amide derivatives of aniline-related compounds are disclosed, including salts thereof, and compositions, preparations and uses thereof. In certain embodiments, the amide derivatives and/or salts thereof show higher solubility in water compared to the corresponding parent aniline-related compounds.

  氨基苯酰衍生物的衍生物被披露，包括其盐，以及它们的组合物、制剂和用途。在某些实施例中，这些氨基苯酰衍生物和/或其盐与相应的母体氨基苯酰相关化合物相比在水中显示出更高的溶解度。
• Antithrombotic Diamides
  申请人：Franciskovich Jeffry Bernard

  公开号：US20090062271A1

  公开（公告）日：2009-03-05

  This application relates to a compound of formula I (or a pharmaceutically acceptable salt of the compound) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.

  本申请涉及公式I化合物（或其药学上可接受的盐），其制药组合物，以及其作为Xa因子和/或凝血酶抑制剂的用途，以及其制备过程和中间体。
• 3-SUBSTITUTED-1,2,3-TRIAZIN-4-ONE'S AND 3 SUBSTITUTED 1,3-PYRIMIDINONE'S FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES
  申请人：Mueller Rudolf

  公开号：US20100267728A1

  公开（公告）日：2010-10-21

  This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stroke-induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning. In a particular aspect, the invention relates to compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.

  本发明涉及化合物、药物组合物和方法，用于预防和治疗脑血液不足，包括增强大脑网络中负责基本和高级行为的突触中受体功能。这些大脑网络参与调节呼吸和认知能力，与记忆障碍相关，如多种痴呆症观察到的那样，以及在不同大脑区域之间的神经活动失衡中，如帕金森病、精神分裂症、呼吸抑制、睡眠呼吸暂停、注意力缺陷多动障碍和情感或情绪障碍中，以及神经营养因子缺乏有关的疾病，以及呼吸方面的疾病，如酒精、鸦片、阿片、巴比妥酸盐、麻醉剂或神经毒素过量，或呼吸抑制是由中枢性睡眠呼吸暂停、中风引起的中枢性睡眠呼吸暂停、阻塞性睡眠呼吸暂停、先天性低通气综合征、肥胖性低通气综合征、婴儿猝死综合征、雷特综合征、脊髓损伤、创伤性脑损伤、切尼-斯托克斯呼吸、温迪恩氏诅咒、普拉德-威利综合征和溺水等医学情况引起的。在特定方面，本发明涉及用于治疗此类疾病的化合物以及使用这些化合物进行此类治疗的方法。
• Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
  申请人：——

  公开号：US20030148926A1

  公开（公告）日：2003-08-07

  Novel C-13 2 -COXR 1 , C-17 2 -COXR 2 and C-13 2 -COXR 1 , C-17 2 -COXR 1 derivatives of chlorophyll and bacteriochlorophyll compounds are provided wherein X is O, S or N and R 1 and R 2 , the same or different, may be an optionally substituted hydrocarbyl, amino acid, peptide, protein or saccharide radical. The compounds are for use in photodynamic therapy (PDT), for diagnosis of tumors, and for killing cells and infectious agents such as bacteria and virus, both in biological products and in living tissues.

  新颖的 C-13 2 -COXR 1 , C-17 2 -COXR 2 和 C-13 2 -COXR 1 , C-17 2 -COXR 1 提供了叶绿素和细菌叶绿素化合物的衍生物，其中 X 是 O、S 或 N，R 1 和 R 2 可以是任选取代的烃基、氨基酸、肽、蛋白质或糖基。这些化合物可用于光动力疗法（PDT）、肿瘤诊断以及杀死生物制品和活体组织中的细胞和传染性病原体，如细菌和病毒。